Clinical trial
Ketamine Associated With Opioids in Refractory Cancer Pain Treatment
NCT00484484 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT00484484 |
|---|---|
| Title | Ketamine Associated With Opioids in Refractory Cancer Pain Treatment |
| Official title | Efficacy of Low Analgesic Doses of Ketamine Associated With Opioids in Refractory Cancer Pain Treatment |
| Acronym | KETADOL |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Ketamine |
| Enrollment | 100 |
| Start date | May 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jun 11, 2007 |
| Last update posted | May 4, 2011 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: